U.S. FDA Issues Warning Letter to Aurobindo Pharma's Subsidiary

According to The Hindu, a manufacturing unit of Eugia Pharma Specialities near Hyderabad received a warning letter from the U.S. FDA.

Reported by The Hindu

By AUZZ Newsdesk (The Hindu)

Published Friday 14 August 2026 at 7:40 am AEST 2 min read

Download PDF

Save article

Language

U.S. FDA Issues Warning Letter to Aurobindo Pharma's Subsidiary

Listen

0:000:00

Comments (0)

Be the first to comment.

Related coverage

Science

Study suggests India's per-unit space launch costs are highest

According to an analysis, India reportedly incurs the highest per-unit space launch cost globally despite its reputation in the sector.

AUZZ Newsdesk (The Hindu) · 17 min ago

World

Search for IIT Indore Techie Called Off, Focus Shifts to Digital Footprint

According to The Hindu, authorities have concluded the physical search for Advait Upadhyay, who was reported missing from Shivagange Hill.

AUZZ Newsdesk (The Hindu) · 17 min ago

World

Identity and Home Explored for Indians Abroad Ahead of 2026 Independence Day

A recent article by The Hindu examines the complex meaning of home, memory, identity, and belonging for Indians living abroad, spanning three continents.

AUZZ Newsdesk (The Hindu) · 17 min ago

U.S. FDA Issues Warning Letter to Aurobindo Pharma's Subsidiary

Comments (0)

Study suggests India's per-unit space launch costs are highest

Search for IIT Indore Techie Called Off, Focus Shifts to Digital Footprint

Identity and Home Explored for Indians Abroad Ahead of 2026 Independence Day

NHRC Notifies Home Ministry on CRPF Suicide Cases

Coriander Prices Reportedly Exceed Rs 200/kg Amid Supply Disruptions

Goods Transporters' Strike Continues in Pakistan, Talks Resume